U.S. Physical Therapy (USPH) Stock Price, News & Analysis

Company Overview

U.S. Physical Therapy, Inc. operates a national network of outpatient physical therapy clinics, providing rehabilitation services to patients recovering from orthopedic injuries, surgeries, neurological conditions and chronic pain. Founded in 1991, the Company has grown through a combination of organic expansion and strategic acquisitions, establishing more than 700 clinics across 33 U.S. states. Its services include one-on-one physical therapy, occupational therapy, sports medicine, industrial rehabilitation and wellness programs designed to improve patients’ mobility, strength and functional independence.

In addition to traditional physical therapy, U.S. Physical Therapy offers specialized programs such as vestibular rehabilitation, pelvic health services and women’s health therapy. The Company leverages evidence-based treatment protocols and state-of-the-art equipment to tailor care plans for athletes, seniors and workers seeking to return to full activity. Many clinics also partner with local employers and sports teams to provide on-site preventive services, ergonomics assessments and performance training, underscoring its commitment to community health and injury prevention.

Headquartered in Dallas, Texas, U.S. Physical Therapy serves metropolitan and rural markets, focusing on regions with growing demand for outpatient rehabilitation. The Company’s regional management teams oversee clinical operations, quality assurance and patient satisfaction initiatives to maintain high standards of care. Clinics employ licensed physical therapists, physical therapist assistants and support staff who participate in ongoing professional development and in-house training programs.

Leadership is spearheaded by President and Chief Executive Officer Steven J. Edwards, who joined the Company in 2006 and has driven its expansion and commitment to clinical excellence. U.S. Physical Therapy’s board of directors comprises seasoned executives and healthcare experts who guide strategic growth, acquisitions and operational efficiency. With a track record of steady geographic diversification and service innovation, the Company continues to build its footprint in the outpatient rehabilitation market.

Key Stats

• Today's Range: $79.51 to $82.18
• 50-Day Range: $70.78 to $82.14
• 52-Week Range: $62.77 to $101.20
• Volume: 158,966 shs
• Average Volume: 121,404 shs
• Market Capitalization: $1.25 billion
• P/E Ratio: 37.68
• Dividend Yield: 2.19%
• Price Target: $109.00
• Consensus Rating: Buy

U.S. Physical Therapy Stock Analysis - MarketRank™

U.S. Physical Therapy scored higher than 67% of companies evaluated by MarketBeat, and ranked 273rd out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

U.S. Physical Therapy has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

U.S. Physical Therapy has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.74%

Earnings Growth

Earnings for U.S. Physical Therapy are expected to grow by 9.74% in the coming year, from $2.67 to $2.93 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of U.S. Physical Therapy is 37.68, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of U.S. Physical Therapy is 37.68, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.61.

Price to Earnings Growth Ratio

U.S. Physical Therapy has a PEG Ratio of 3.98. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

U.S. Physical Therapy has a P/B Ratio of 2.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.15% of the float of U.S. Physical Therapy has been sold short.

Short Interest Ratio / Days to Cover

U.S. Physical Therapy has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in U.S. Physical Therapy has recently increased by 3.21%, indicating that investor sentiment is decreasing.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

U.S. Physical Therapy pays a meaningful dividend of 2.19%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

U.S. Physical Therapy has been increasing its dividend for 6 years.

Dividend Coverage

The dividend payout ratio of U.S. Physical Therapy is 82.57%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 61.43% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.15% of the float of U.S. Physical Therapy has been sold short.

Short Interest Ratio / Days to Cover

U.S. Physical Therapy has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in U.S. Physical Therapy has recently increased by 3.21%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: 0.63

News Sentiment

U.S. Physical Therapy has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for U.S. Physical Therapy this week, compared to 5 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, U.S. Physical Therapy insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $31,204.00 in company stock.

Percentage Held by Insiders

Only 2.00% of the stock of U.S. Physical Therapy is held by insiders.

USPH Stock Analysis - Frequently Asked Questions

How have USPH shares performed this year?

U.S. Physical Therapy's stock was trading at $88.71 at the start of the year. Since then, USPH shares have decreased by 7.4% and is now trading at $82.14.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings results on Wednesday, May, 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.02. The company's revenue for the quarter was up 18.0% on a year-over-year basis.
Read the conference call transcript.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that U.S. Physical Therapy investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AU Optronics (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Record date for 4/11 Dividend: 3/14/2025
• Ex-Dividend for 4/11 Dividend: 3/14/2025
• Dividend Payable: 4/11/2025
• Last Earnings: 5/07/2025
• Record date for 6/13 Dividend: 5/23/2025
• Ex-Dividend for 6/13 Dividend: 5/23/2025
• Dividend Payable: 6/13/2025
• Today: 7/06/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Health Care Facilities
• Current Symbol: NYSE:USPH
• CIK: 885978
• Web: www.usph.com
• Phone: (713) 297-7000
• Fax: 713-297-7090
• Employees: 7,028
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $109.00
• High Stock Price Target: $115.00
• Low Stock Price Target: $98.00
• Potential Upside/Downside: +32.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.18
• Trailing P/E Ratio: 37.68
• Forward P/E Ratio: 30.76
• P/E Growth: 3.98
• Net Income: $31.42 million
• Net Margins: 4.57%
• Pretax Margin: 8.98%
• Return on Equity: 7.89%
• Return on Assets: 3.51%

Debt

• Debt-to-Equity Ratio: 0.32
• Current Ratio: 1.17
• Quick Ratio: 1.17

Sales & Book Value

• Annual Sales: $699.46 million
• Price / Sales: 1.78
• Cash Flow: $3.47 per share
• Price / Cash Flow: 23.68
• Book Value: $32.46 per share
• Price / Book: 2.53

Miscellaneous

• Outstanding Shares: 15,192,000
• Free Float: 14,888,000
• Market Cap: $1.25 billion
• Optionable: Optionable
• Beta: 1.44